Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Andreas Burchert

Andreas Burchert


Academic history

Andreas Burchert, MD, PhD, is the Deputy Clinical Director and a Senior Physician at the Philipps-University Marburg, Marburg, Germany.

Speaking on novel therapies for AML

Prof. Burchert’s primary research focus is on novel therapies for the treatment of acute myeloid leukemia (AML). In particular, Prof. Burchert has recently worked on a study investigating whether FLT3-ITD inhibition with sorafenib can prevent AML relapse.